Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2004, p. 1989-1992, Vol. 48, No. 6
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.6.1989-1992.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum
Nina Singh,1,2* Asia Obman,1 Shahid Husain,2 Sherrie Aspinall,1 Sue Mietzner,1 and Janet E. Stout1
Veterans Affairs Medical Center and,1
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania2
Received 4 December 2003/
Returned for modification 20 January 2004/
Accepted 10 February 2004
The possible reactivities of commonly used antibiotics of fungal, nonfungal, and nonmicrobial or synthetic sources with the Platelia Aspergillus galactomannan assay were assessed. For drugs that tested positive, the minimal concentration of the antibiotic in serum that yielded a positive test (index, >0.5) was determined. At undiluted concentrations, piperacillin and multiple lots of piperacillin-tazobactam tested positive, whereas amoxicillin, ampicillin-sulbactam, nafcillin, cefazolin, ceftazidime, erythromycin, gentamicin, and levofloxacin tested negative. All three lots of piperacillin-tazobactam and all bags within each lot tested positive, with a mean index value of 5.168. At achievable concentrations in serum, however, only one of three lots of piperacillin-tazobactam yielded a positive test. Concentrations of 75, 150, and 300 µg/ml of serum tested positive with the Platelia Aspergillus enzyme immunoassay, whereas lower concentrations, mimicking the trough levels, tested negative. Thus, while achievable serum piperacillin-tazobactam concentrations may potentially result in a positive test for galactomannan, the timing of the collection of serum samples from patients may influence the test results, with reactivity being less likely in samples collected at trough levels or prior to the administration of a dose of the antibiotic.
* Corresponding author. Mailing address: VA Medical Center, Infectious Disease Section, University Dr. C, Pittsburgh, PA 15240. Phone: (412) 688-6179. Fax: (412) 688-6950. E-mail:
nis5+{at}pitt.edu.
Antimicrobial Agents and Chemotherapy, June 2004, p. 1989-1992, Vol. 48, No. 6
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.6.1989-1992.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Xavier, M. O., Pasqualotto, A. C., Cardoso, I. C. E., Severo, L. C.
(2009). Cross-Reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus Species in the Commercial Platelia Aspergillus Enzyme Immunoassay. CVI
16: 132-133
[Abstract]
[Full Text]
-
Zmeili, O.S., Soubani, A.O.
(2007). Pulmonary aspergillosis: a clinical update. QJM
100: 317-334
[Abstract]
[Full Text]
-
Machetti, M., Majabo, M. J., Furfaro, E., Solari, N., Novelli, A., Cafiero, F., Viscoli, C.
(2006). Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. J Antimicrob Chemother
58: 806-810
[Abstract]
[Full Text]
-
Leroy, P., Smismans, A., Seute, T.
(2006). Invasive Pulmonary and Central Nervous System Aspergillosis After Near-Drowning of a Child: Case Report and Review of the Literature. Pediatrics
118: e509-e513
[Abstract]
[Full Text]
-
Aubry, A., Porcher, R., Bottero, J., Touratier, S., Leblanc, T., Brethon, B., Rousselot, P., Raffoux, E., Menotti, J., Derouin, F., Ribaud, P., Sulahian, A.
(2006). Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with {beta}-Lactam Antibiotics in Patients with Hematological Disorders. J. Clin. Microbiol.
44: 389-394
[Abstract]
[Full Text]
-
Pickering, J. W., Sant, H. W., Bowles, C. A. P., Roberts, W. L., Woods, G. L.
(2005). Evaluation of a (1->3)-{beta}-D-Glucan Assay for Diagnosis of Invasive Fungal Infections. J. Clin. Microbiol.
43: 5957-5962
[Abstract]
[Full Text]
-
Scotter, J. M., Chambers, S. T.
(2005). Comparison of Galactomannan Detection, PCR-Enzyme-Linked Immunosorbent Assay, and Real-Time PCR for Diagnosis of Invasive Aspergillosis in a Neutropenic Rat Model and Effect of Caspofungin Acetate. CVI
12: 1322-1327
[Abstract]
[Full Text]
-
Bart-Delabesse, E., Basile, M., Al Jijakli, A., Souville, D., Gay, F., Philippe, B., Bossi, P., Danis, M., Vernant, J.-P., Datry, A.
(2005). Detection of Aspergillus Galactomannan Antigenemia To Determine Biological and Clinical Implications of Beta-Lactam Treatments. J. Clin. Microbiol.
43: 5214-5220
[Abstract]
[Full Text]
-
Machetti, M., Furfaro, E., Viscoli, C.
(2005). Galactomannan in Piperacillin-Tazobactam: How Much and to What Extent?. Antimicrob. Agents Chemother.
49: 3984-3985
[Full Text]
-
Singh, N., Paterson, D. L.
(2005). Aspergillus Infections in Transplant Recipients. Clin. Microbiol. Rev.
18: 44-69
[Abstract]
[Full Text]
-
Mattei, D., Rapezzi, D., Mordini, N., Cuda, F., Lo Nigro, C., Musso, M., Arnelli, A., Cagnassi, S., Gallamini, A.
(2004). False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment. J. Clin. Microbiol.
42: 5362-5363
[Abstract]
[Full Text]